MycoBiomDB – Record Details (MyCo_1504)

Biomarker Record Details

Database ID: MyCo_1504
DB IDMyCo_1504
TitleRole of serum (1,3)-β-d-glucan assay in early diagnosis of invasive fungal infections in a neonatal intensive care unit
Year2017
PMID29144965
Fungal Diseases involvedInvasive fungal infection
Associated Medical ConditionNeonatal sepsis
GenusCandida
Speciesspp.
OrganismCandida spp.
Ethical StatementThe Research Ethics Committee of Mansoura Faculty of Medicine approved the study, and written informed consents were obtained from the parents of all neonates included in the study.
Site of InfectionNone
Opportunistic invasiveInvasive
Sample typeBody fluid
Sample sourceSerum
Host GroupHuman
Host Common nameHuman
Host Scientific nameHomo sapiens
Biomarker NameBDG
Biomarker Full Name1-3-beta-D-Glucan
Biomarker TypeDiagnostic
BiomoleculeProtein
Geographical LocationEgypt
CohortA prospective multicenter clinical trial conducted on infants at high risk for invasive fungal infections, with suspected late onset sepsis, admitted to a neonatal intensive care unit at Mansoura University Children’s Hospital and Mansoura General Hospital between March 2014 and February 2016. A total of 77 newborn infants with high risk of invasive fungal infection were classified based on blood culture into three groups: no fungemia (41 neonates with proven bacterial sepsis), suspected fungemia (25 neonates with negative blood culture), and definite fungemia group (11 neonates with culture-proven Candida).
Cohort No.77
Age GroupNone
P ValueNone
Sensitivity0.636
Specificity0.951
Positive Predictive Value0.778
MICNone
Fold ChangeNone
PathwayNone
Disease Introduction MechanismNone
TechniqueAnalytic
Analysis MethodDynamiker Fungus analysis
ELISA kitsDynamiker Fungus Kit (Dynamiker Biotechnology, Tianjin, China)
Assay DataNone
Validation Techniques usedDynamiker Fungus analysis
Up Regulation Down RegulationPositive
Sequence DataNone
External LinkNone